Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROFOUND Study: Development and Validation of a Multi-cancer Early Detection Model Based on Peripheral Blood Multi-omic Analysis and Machine Learning: a Multicenter, Prospective, Observational, Case-control Study

NCT06217900 is registered in ClinicalTrials.gov with Shanghai Weihe Medical Laboratory Co., Ltd. as lead sponsor.

NCT NCT06217900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06217900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROFOUND Study: Development and Validation of a Multi-cancer Early Detection Model Based on Peripheral Blood Multi-omic Analysis and Machine Learning: a Multicenter, Prospective, Observational, Case-control Study
Lead sponsor
Shanghai Weihe Medical Laboratory Co., Ltd.
Phase
Observational
Overall status
Active, not recruiting
Start date
December 28, 2023
Completion date
March 31, 2027
Enrollment
16,666 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

cancer